Basilea Pharmaceutica AG - Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea
Basilea Pharmaceutica AG / Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone ...Articles similaires à Basilea Pharmaceutica AG - Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea
• Sources :
• Mots clés :
• Participer :
• Suivre l'actualité :
BACK TO TOP
